Perineural Local Anesthetic Administration With a Continuous Infusion Versus Automatic Intermittent Boluses

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

March 12, 2021

Study Completion Date

March 16, 2021

Conditions
Pain, AcuteAnesthesia, LocalTrauma Injury
Interventions
DEVICE

Continuous Infusion

A continuous infusion of ropivacaine 0.2% (6 mL/hr, 4 mL patient controlled bolus with 30-minute lockout) will be initiated in the recovery room.

DEVICE

Automated Intermittent Boluses

Administration of automated intermittent boluses of ropivacaine 0.2% (8 mL every 2 hr with 4 mL patient controlled bolus with 30-minute lockout) will be initiated in the recovery room, but with a 5-hour delay for the first bolus (can be overridden by patients if they would like to initiate their perineural infusion earlier than 5 hours).

Trial Locations (1)

92103

UCSD Medical Center (Hillcrest and Thornton), San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT04458467 - Perineural Local Anesthetic Administration With a Continuous Infusion Versus Automatic Intermittent Boluses | Biotech Hunter | Biotech Hunter